Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −43,966−100.0% | Sold out | Holders |
| Q2 2025 | 43,966 | $1.14M | 0.4% | −27,294−38.3% | ReducedConverted for a 1-for-15 split | Holders |
| Q1 2025 | 1,068,899 | $726.9K | 0.4% | −963,969−47.4% | Reduced | Holders |
| Q4 2024 | 2,032,868 | $1.89M | 0.8% | +35,648+1.8% | Added | Holders |
| Q3 2024 | 1,997,220 | $2.60M | 1.1% | −169,212−7.8% | Reduced | Holders |
| Q2 2024 | 2,166,432 | $2.69M | 1.3% | −3,665,133−62.8% | Reduced | Holders |
| Q1 2024 | 5,831,565 | $5.45M | 2.4% | −141,822−2.4% | Reduced | Holders |
| Q4 2023 | 5,973,387 | $3.37M | 1.3% | +1,163,786+24.2% | Added | Holders |
| Q3 2023 | 4,809,601 | $2.86M | 1.4% | −4,451,116−48.1% | Reduced | Holders |
| Q2 2023 | 9,260,717 | $5.33M | 2.9% | +9,260,717 | New | Holders |